Advertisement
Screener

VivoSim Labs, Inc. (VIVS) EBITDA

VivoSim Labs, Inc. (VIVS) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$2.72M; Operating income (m); Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA -$3.14M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$2.70M*; Operating income -$2.75M; Depreciation and amortization $52.00K*.
  • 2025-09-30: Basis Reported; EBITDA -$2.58M*; Operating income -$2.63M; Depreciation and amortization $59.00K*.

Complete source-backed ebitda history.

Available history
2011-03-31 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$2.72M(m)(m)(m)-15105.56%$23.00K-$3.21M(m)$1.13M$1.65M$3.00K
2026-03-31Reported-$3.14M(m)(m)(m)-7860.00%(m)(m)(m)(m)(m)(m)
2025-12-31Reported-$2.70M*-$2.75M$52.00K*$26.00K-10376.92%*$0.00*-$2.27M*$0.00$1.14M$1.64M$0.00
2025-09-30Reported-$2.58M*-$2.63M$59.00K*$28.00K-9200.00%*$0.00*-$2.38M*$0.00$923.00K$1.74M$2.00K
2025-06-30Reported-$2.85M(m)(m)(m)-7713.51%$0.00-$3.94M$0.00$1.00M$1.95M$0.00
2025-03-31Reported-$3.09M(m)(m)(m)-6064.71%(m)(m)(m)(m)(m)(m)
2024-12-31Reported-$3.40M*-$3.47M$67.00K*$24.00K-14170.83%*$0.00*-$1.80M*$2.00K$1.78M$1.71M$0.00
2024-09-30Reported-$2.54M*-$2.61M$68.00K*$30.00K-8466.67%*$13.00K*-$2.64M*$1.00K$984.00K$1.65M$0.00
2024-06-30Reported-$3.32M(m)(m)(m)-8502.56%$0.00-$2.98M$2.00K$1.40M$2.02M$2.00K
2024-03-31Reported-$3.03M(m)(m)(m)-10431.03%(m)(m)(m)(m)(m)(m)
2023-12-31Reported-$3.61M*-$3.68M$71.00K*$5.00K-72180.00%*$0.00*-$3.52M*$0.00$1.43M$2.25M$0.00
2023-09-30Reported-$4.04M*-$4.12M$71.00K*$0.00(m)$27.00K*-$3.15M*$0.00$1.33M$2.78M$0.00
2023-06-30Reported-$4.13M(m)(m)(m)-5504.00%$15.00K-$5.31M$0.00$1.67M$2.60M$2.00K
2023-03-31Reported-$7.72M(m)(m)(m)-4765.43%(m)(m)(m)(m)(m)(m)
2022-12-31Reported-$3.23M*-$3.36M$130.00K*$131.00K-2464.89%*$41.00K*-$3.04M*(m)$1.19M$2.31M$0.00
2022-09-30Reported-$3.30M*-$3.35M$54.00K*$77.00K-4285.71%*$119.00K*-$2.22M*(m)$1.23M$2.20M$0.00
2022-06-30Reported-$3.19M(m)(m)(m)(m)$74.00K-$2.41M(m)$1.02M$2.22M$2.00K
2022-03-31Reported-$1.87M(m)(m)(m)-124.47%(m)(m)(m)(m)(m)(m)
2021-12-31Reported-$3.46M*-$3.50M$37.00K*$0.00(m)$133.00K*-$3.36M*(m)$926.00K$2.57M$2.00K
2021-09-30Reported-$3.47M*-$3.51M$34.00K*$0.00(m)$29.00K*-$2.14M*(m)$679.00K$2.83M$0.00
2021-06-30Reported-$2.53M(m)(m)(m)(m)$194.00K-$1.41M(m)$580.00K$1.98M$0.00
2021-03-31Reported-$2.58M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31Reported-$2.48M*-$2.49M$10.00K*$0.00(m)$294.00K*-$1.49M*$0.00$402.00K$2.09M$0.00
2020-09-30Reported-$8.95M*-$8.95M$4.00K*$0.00(m)$0.00*-$7.15M*$0.00$28.00K$8.92M$0.00
2020-06-30Reported-$2.78M(m)(m)(m)(m)$0.00-$2.57M$0.00$0.00$2.79M$2.00K
2020-03-31Reported-$2.89M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31Reported-$4.48M*-$5.23M$757.00K*$298.00K-1502.35%*$0.00*-$583.00K*$13.00K$145.00K$5.37M$0.00
2019-09-30Reported-$6.65M*-$6.83M$174.00K*$1.23M-540.89%*(m)-$5.16M*$264.00K$1.45M$6.35M$2.00K
2019-06-30Reported-$6.32M(m)(m)(m)-945.51%(m)-$5.93M$51.00K$3.82M$3.31M$0.00
2019-03-31Reported-$7.01M(m)(m)(m)-1030.29%(m)(m)(m)(m)(m)(m)
2018-12-31Reported-$6.27M*-$6.53M$254.00K*$779.00K-805.13%*$26.00K*-$3.95M*$136.00K$3.78M$3.39M$0.00
2018-09-30Reported-$5.73M*-$6.01M$282.00K*$943.00K-607.32%*$11.00K*-$4.32M*$125.00K$3.19M$3.64M$0.00
2018-06-30Reported-$7.29M(m)(m)(m)-1057.91%$0.00-$7.02M$120.00K$3.38M$4.77M$3.00K
2018-03-31Reported-$7.28M(m)(m)(m)-658.64%(m)(m)(m)(m)(m)(m)
2017-12-31Reported-$7.59M*-$7.91M$315.00K*$1.15M-658.63%*$34.00K*-$6.44M*$192.00K$4.00M$4.87M$0.00
2017-09-30Reported-$9.26M*-$9.58M$321.00K*$1.35M-683.25%*$45.00K*-$6.15M*$254.00K$4.94M$5.74M$0.00
2017-06-30Reported-$9.87M(m)(m)(m)-997.37%$11.00K-$10.65M$301.00K$5.03M$5.86M$0.00
2017-03-31Reported-$10.36M(m)(m)(m)-1344.10%(m)(m)(m)(m)(m)(m)
2016-12-31Reported-$9.31M*-$9.63M$322.00K*(m)(m)$609.00K*(m)(m)$5.02M$5.55M$1.00K
2016-09-30Reported-$9.23M*-$9.48M$251.00K*(m)(m)$440.00K*(m)(m)$4.54M$5.92M$0.00
2016-06-30Reported-$8.53M(m)(m)(m)-1264.99%$12.00K(m)(m)$4.44M$5.06M$22.00K
2016-03-31Reported-$8.18M(m)(m)(m)-6988.03%(m)(m)(m)(m)(m)(m)
2015-12-31Reported-$10.23M*-$10.47M$236.00K*(m)(m)$161.00K*(m)(m)$4.59M$6.21M$0.00
2015-09-30Reported-$11.10M*-$11.28M$189.00K*(m)(m)$415.00K*(m)(m)$4.74M$6.85M$0.00
2015-06-30Reported-$8.32M(m)(m)(m)-3982.30%$1.14M(m)(m)$4.14M$4.62M$3.00K
2015-03-31Reported-$7.83M(m)(m)(m)-4475.43%(m)(m)(m)(m)(m)(m)
2014-12-31Reported-$6.83M*-$6.96M$126.00K*(m)(m)$291.00K*(m)(m)$3.24M$3.88M$0.00
2014-09-30Reported-$8.84M*-$8.96M$112.00K*(m)(m)$338.00K*$6.30M*(m)$3.23M$5.78M$0.00
2014-06-30Reported-$6.31M(m)(m)(m)(m)$238.00K$3.40M(m)$2.81M$3.69M(m)
2014-03-31Reported-$6.59M(m)(m)(m)2495.08%(m)(m)(m)(m)(m)(m)
2013-12-31Reported-$4.53M*-$4.63M$98.00K*(m)(m)-$20.00K*-$3.90M*(m)$2.38M$2.38M(m)
2013-09-30Reported-$5.50M*-$5.60M$97.00K*(m)(m)$13.00K*-$3.59M*(m)$1.62M$4.00M(m)
2013-06-30Reported-$3.64M(m)(m)(m)-3434.91%$163.00K-$2.66M(m)$1.48M$2.36M(m)
2013-03-31Reported-$3.94M*-$4.03M$80.00K(m)(m)$137.00K-$2.75M(m)$1.45M$2.79M(m)
2012-12-31Reported-$2.84M(m)(m)(m)335.33%$101.00K*-$1.98M*(m)$1.13M$2.14M(m)
2012-09-30Reported(m)-$3.62M(m)(m)(m)(m)(m)(m)$1.11M$2.98M(m)
2012-06-30Reported-$1.43M(m)(m)(m)-552.12%$72.00K-$1.86M(m)$653.00K$1.06M(m)
2012-03-31Reported-$1.31M(m)(m)(m)-1093.77%$6.00K-$3.56M(m)$547.00K$902.00K(m)
2011-12-31Reported-$698,905.00(m)(m)(m)-192.61%(m)(m)(m)(m)(m)(m)
2011-09-30Reported-$604.93K*-$622.43K$17.50K*(m)(m)$7.63K*-$647.00(m)$304.25K$550.16K$0.00
2011-06-30Reported-$456.80K*-$473.64K$16.83K*(m)(m)(m)-$297.57K*(m)$311.07K$335.95K(m)
2011-03-31Reported-$476,357.00(m)(m)(m)-237.24%(m)-$311.77K(m)$398.66K$243.49K(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-03-31Reported-$11.27M(m)(m)(m)-8604.58%$0.00-$10.83M$0.00$4.19M$7.43M$2.00K
2025-03-31Reported-$12.35M(m)(m)(m)-8576.39%$13.00K-$9.46M$5.00K$5.03M$7.73M$2.00K
2024-03-31Reported-$14.81M(m)(m)(m)-13583.49%$42.00K-$14.65M(m)$5.50M$9.70M$2.00K
2023-03-31Reported-$17.44M(m)(m)(m)-4712.97%$396.00K-$12.41M(m)$8.88M$9.22M$2.00K
2022-03-31Reported-$11.34M(m)(m)(m)-755.80%$409.00K-$8.45M(m)$3.32M$9.66M$2.00K
2021-03-31Reported-$16.79M(m)(m)(m)(m)$405.00K-$13.32M$0.00$1.10M$15.72M$2.00K
2020-03-31Reported-$20.33M(m)(m)(m)-925.91%$0.00-$14.88M$328.00K$5.28M$18.06M$2.00K
2019-03-31Reported-$26.29M(m)(m)(m)-850.66%$79.00K-$20.38M$482.00K$14.75M$15.13M$3.00K
2018-03-31Reported-$34M(m)(m)(m)-738.74%$226.00K-$28.86M$1.03M$17.96M$20.89M$2.00K
2017-03-31Reported-$37.43M(m)(m)(m)-1181.75%$1.35M(m)(m)$19.55M$22.30M$23.00K
2016-03-31Reported-$37.83M(m)(m)(m)-4693.30%$2.11M(m)(m)$18.01M$22.12M$3.00K
2015-03-31Reported-$29.83M(m)(m)(m)-9498.41%$1.52M(m)(m)$12.92M$17.95M$0.00
2014-03-31Reported-$20.26M(m)(m)(m)(m)$277.00K-$15.56M(m)$7.97M$13.05M$0.00
2013-12-31Rolling-$17.62M*-$17.99M*$368.00K*(m)(m)$293.00K*-$12.92M*(m)$6.93M*$11.53M*(m)
2013-09-30Rolling-$15.94M*-$16.28M*$348.00K*(m)(m)$414.00K*-$10.99M*(m)$5.68M*$11.29M*(m)
2013-06-30Rolling(m)-$14.30M*(m)(m)(m)(m)(m)(m)$5.17M*$10.27M*(m)
2013-03-31Rolling(m)-$12.02M*(m)(m)(m)(m)(m)(m)$4.34M*$8.97M*(m)
2012-12-31Reported-$9.12M(m)(m)(m)(m)$357.00K-$9.69M(m)$3.44M$7.08M(m)
2012-12-31Rolling(m)-$9.32M*(m)(m)(m)(m)(m)(m)$3.44M*$7.08M*(m)
2011-12-31Reported-$2.24M(m)(m)(m)-230.86%$46.00K-$1.91M(m)$1.42M$1.73M(m)
2010-12-31Reported-$1.12M*-$1.18M$59.00K(m)(m)$48.00K-$820.00K(m)$1.20M$578.00K(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
Silexion Therapeutics Corp (SLXN)$0.001B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70